These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 37238596)

  • 1. Distinct Effects of Familial Parkinson's Disease-Associated Mutations on α-Synuclein Phase Separation and Amyloid Aggregation.
    Xu B; Fan F; Liu Y; Liu Y; Zhou L; Yu H
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganese promotes α-synuclein amyloid aggregation through the induction of protein phase transition.
    Xu B; Huang S; Liu Y; Wan C; Gu Y; Wang D; Yu H
    J Biol Chem; 2022 Jan; 298(1):101469. PubMed ID: 34871547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium promotes α-synuclein liquid-liquid phase separation to accelerate amyloid aggregation.
    Huang S; Xu B; Liu Y
    Biochem Biophys Res Commun; 2022 May; 603():13-20. PubMed ID: 35276458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid-liquid Phase Separation of α-Synuclein: A New Mechanistic Insight for α-Synuclein Aggregation Associated with Parkinson's Disease Pathogenesis.
    Mukherjee S; Sakunthala A; Gadhe L; Poudyal M; Sawner AS; Kadu P; Maji SK
    J Mol Biol; 2023 Jan; 435(1):167713. PubMed ID: 35787838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations.
    Lewis KA; Yaeger A; DeMartino GN; Thomas PJ
    J Bioenerg Biomembr; 2010 Feb; 42(1):85-95. PubMed ID: 20148295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myricetin Inhibits α-Synuclein Amyloid Aggregation by Delaying the Liquid-to-Solid Phase Transition.
    Xu B; Mo X; Chen J; Yu H; Liu Y
    Chembiochem; 2022 Aug; 23(16):e202200216. PubMed ID: 35657723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein phase separation and amyloid aggregation are modulated by C-terminal truncations.
    Huang S; Mo X; Wang J; Ye X; Yu H; Liu Y
    FEBS Lett; 2022 Jun; 596(11):1388-1400. PubMed ID: 35485974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregation and phase separation of α-synuclein in Parkinson's disease.
    Han W; Wei M; Xu F; Niu Z
    Chem Commun (Camb); 2024 Jun; 60(52):6581-6590. PubMed ID: 38808534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and morphological classification of disease-associated alpha-synuclein mutants aggregates.
    Tanaka G; Yamanaka T; Furukawa Y; Kajimura N; Mitsuoka K; Nukina N
    Biochem Biophys Res Commun; 2019 Jan; 508(3):729-734. PubMed ID: 30528390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of age-associated alpha-synuclein aggregation in a conditional transgenic mouse model of Parkinson's disease: Implications for Lewy body formation.
    Li J; Ng KW; Sung CC; Chung KKK
    J Neurochem; 2024 Jul; 168(7):1215-1236. PubMed ID: 38693066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
    Sahay S; Ghosh D; Singh PK; Maji SK
    Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin Interacts with α-Synuclein Condensates To Inhibit Amyloid Aggregation under Phase Separation.
    Xu B; Chen J; Liu Y
    ACS Omega; 2022 Aug; 7(34):30281-30290. PubMed ID: 36061735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive assay reveals structural requirements for α-synuclein fibril growth.
    Dhavale DD; Tsai C; Bagchi DP; Engel LA; Sarezky J; Kotzbauer PT
    J Biol Chem; 2017 Jun; 292(22):9034-9050. PubMed ID: 28373279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein.
    Rutherford NJ; Moore BD; Golde TE; Giasson BI
    J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Label-free detection of early oligomerization of α-synuclein and its mutants A30P/E46K through solid-state nanopores.
    Li X; Tong X; Lu W; Yu D; Diao J; Zhao Q
    Nanoscale; 2019 Mar; 11(13):6480-6488. PubMed ID: 30892349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of alpha-synuclein oligomerization and aggregation in cellular and animal models of Parkinson's disease.
    Wan OW; Chung KK
    PLoS One; 2012; 7(6):e38545. PubMed ID: 22701661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryo-EM structure of amyloid fibril formed by α-synuclein hereditary A53E mutation reveals a distinct protofilament interface.
    Sun C; Zhou K; DePaola P; Shin WS; Hillyer T; Sawaya MR; Zhu R; Peng C; Zhou ZH; Jiang L
    J Biol Chem; 2023 Apr; 299(4):104566. PubMed ID: 36871760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The newly discovered Parkinson's disease associated Finnish mutation (A53E) attenuates α-synuclein aggregation and membrane binding.
    Ghosh D; Sahay S; Ranjan P; Salot S; Mohite GM; Singh PK; Dwivedi S; Carvalho E; Banerjee R; Kumar A; Maji SK
    Biochemistry; 2014 Oct; 53(41):6419-21. PubMed ID: 25268550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson's disease: ex vivo and in vitro studies.
    Horvath I; Iashchishyn IA; Moskalenko RA; Wang C; Wärmländer SKTS; Wallin C; Gräslund A; Kovacs GG; Morozova-Roche LA
    J Neuroinflammation; 2018 Jun; 15(1):172. PubMed ID: 29866153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.